Zoetis Selected to Provide Vaccines for Rabies Vaccine Bank Program | RYT9

by time news

Zoetis Selected to Provide Vaccines in OIE’s Rabies Vaccine Bank Program

The World Organization for Animal Health (OIE) has selected Zoetis as one of only two vaccine producers certified through a transparent competitive procurement process to provide vaccines. with Rabies Vaccine Bank for four years. The Vaccine Bank aims to reduce human mortality from canine-borne rabies in OIE member countries to 0 by 2025. . 2030

“We are delighted to have been selected to be an OIE partner for the international fight against rabies,” said Timma Driscoll, Soetis’ senior vice president of International Business Development. “This selection reflects the quality and efficacy of the Zoetis vaccine, as well as its commitment and awareness-raising capabilities. Cooperation and education with health stakeholders in different regions Zoetis remains committed to the fight against deadly diseases that affect both animals and humans. The supply of vaccines to the vaccine bank reflects its ability to fight infectious diseases. cross border including diseases transmitted from animals to humans as well.”

This vaccine bank was established by OIE To support the provision of quality vaccines manufactured according to OIE standards to be readily available and sufficient to meet the needs in various areas. especially in developing countries The important role of Vaccine Bank is to reduce the burden of procurement process. causing government agencies and private organizations Local non-governmental organizations (NGOs) can focus more fully on the design of vaccine administration guidelines. And there is a sufficient number of quality vaccines at an affordable price.

Glenn David, Soetis Vice Chairman and Group President, said: “Cooperation with OIE and alliance with the World Health Organization or WHO) to eliminate dog-borne rabies. It is another important goal for Zoetis One Health’s sustainability and an important opportunity to support the management of diseases. that affects both the animal and the next person.”

According to the OIE, 75% of emerging diseases are of animal origin. This statement aligns with one of the company’s goals in Driven to Care, a long-term, sustainable solution to combat disease that plagues both animals and humans. The Zoetis Center for Transboundary and Emerging Diseases (CTED) has developed a vaccine for emerging diseases identified by the WHO and continuing to have a serious impact around the world.

Since the establishment of the Rabies Vaccine Bank of OIE came up there Zoetis has sold and shipped more than 26 million doses of the rabies vaccine to African and Asian countries. The aforementioned vaccine bank is one of the two vaccine banks established by The OIE and another vaccine bank, the Peste des Petits Ruminants (PPR) Vaccine Bank. OIE as well

OIE Vaccine Bank has received financial support from many countries and agencies such as Australia, Canada, China, European Union, France, Germany, Japan, Korea, New Zealand, World Bank. including the Bill and Melinda Gates Foundation. The selection included nine vaccine companies participating in the auction. It is operated by a selection committee with specific and independent expertise. which Zoetis offers Selected as one of two bodies accredited to supply rabies vaccines for dogs to the OIE Vaccine Bank through 2025 by Zoeti’s Rabies Vaccine. It has been certified in many countries around the world.

About Zoetis

As the world’s leading animal health company We drive our business with one purpose: caring for the planet and humanity by improving animal care. Over 70 years of innovation and development in the prediction, prevention, diagnosis and treatment of animal diseases. We continue to stand by the people who keep and take care of the animals. as well as farmers, veterinarians and pet owners around the world. Pharmaceutical products, vaccines, devices and diagnostic tools as well as leading technologies The company differentiates its business in more than 100 countries. As one of the largest US companies according to Fortune magazine’s rankings, we have revenues of $7.8 billion in 2021 with approximately 12,100 employees. See more details at www.zoetis.com .


You may also like

Leave a Comment